REBAMIPIDE: EFFECTIVE DRUG PREVENTION OF NSAID ENTEROPATHY IS POSSIBLE
Prevention of gastrointestinal tract (GIT) complications is the most important element for the rational use of nonsteroidal anti-inflammatory drugs (NSAIDs) and low-dose aspirin (LDA). Proton pump inhibitors (PPIs) have long been the only medication to prevent these complications. However, PPIs are...
Main Authors: | E. V. Moroz, A. E. Karateev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2016-12-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/726 |
Similar Items
-
The frequency and clinical and endoscopic features of mixed NSAIDs-induced gastrointestinal injuries
by: A. P. Balabantseva, et al.
Published: (2018-12-01) -
Naproxen: A universal analgesic with a minimal risk of cardiovascular events
by: A. E. Karateev
Published: (2016-06-01) -
Quantification and qualification of complication risks at use of non-steroid anti-inflammatory drugs as a basis for recommendations on their use and prophylaxis
by: Andrey Evgenyevich Karateev
Published: (2014-03-01) -
What is safer for the gastrointestinal-tract: Coxibs or meloxicam?
by: A. M. Satybaldyev, et al.
Published: (2017-03-01) -
Выбор ингибитора протонной помпы в условиях антитромбоцитарной терапии у коморбидного пациента
Published: (2016-12-01)